2-(4-Methylphenyl)-4-(pyridin-4-yl)pyrimidine-5-carbohydrazide dihydrochloride

Catalog No. :
ACDCFH143
CAS No. :
1046801-89-1
Molecular Formula :
C17H17Cl2N5O
Molecular Weight :
378.26

IUPAC Name:4-(pyridin-4-yl)-2-(p-tolyl)pyrimidine-5-carbohydrazide dihydrochloride

2-(4-Methylphenyl)-4-(pyridin-4-yl)pyrimidine-5-carbohydrazide dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$494.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Methylphenyl)-4-(pyridin-4-yl)pyrimidine-5-carbohydrazide dihydrochloride
IUPAC Name4-(pyridin-4-yl)-2-(p-tolyl)pyrimidine-5-carbohydrazide dihydrochloride
MDL No.MFCD16628283
Molecular FormulaC17H17Cl2N5O
Molecular Weight378.26
SMILESO=C(C1=CN=C(C2=CC=C(C)C=C2)N=C1C3=CC=NC=C3)NN.[H]Cl.[H]Cl
InChI KeyGBGRKAAKNBIYRE-UHFFFAOYSA-N
Synonym1-{[2-(4-methylphenyl)-4-(4-pyridinyl)-5-pyrimidinyl]carbonyl}hydrazinium dichloride;2-(4-methylphenyl)-4-(pyridin-4-yl)pyrimidine-5-carbohydrazide dihydrochloride
CAS No.1046801-89-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACDCFH143 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDCFH143 route product structure diagram
    ACDCFH1431046801-89-1
Inquiry

2. ACDCFH143 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDCFH143 route product structure diagram
    ACDCFH1431046801-89-1
Inquiry

Comments (0)